Under-recognized cardiovascular risk enhancers in women: A call to rethink clinical assessment on risk stratification

IF 4.3 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

American journal of preventive cardiology Pub Date : 2025-02-11 DOI:10.1016/j.ajpc.2025.100942

Albertina M. Ghelfi , Gustavo J. Staffieri , Mildren A. Del-Sueldo , Gonzalo Miranda , Nicolás F. Renna , Rosana M. Quintana , Melisa N. Lassus , María-Rosa Galván , Romina Maldonado , Flavia A. Passarino , Lautaro N. Fierro , Lautaro L. Velez , Laura Graziani , Boris Kisluk , Leonel A. Berbotto , Romina Nieto , Rubén F. Mamprin D´andrea , Guillermo A. Berbotto , Jorge O. Galindez

{"title":"Under-recognized cardiovascular risk enhancers in women: A call to rethink clinical assessment on risk stratification","authors":"Albertina M. Ghelfi , Gustavo J. Staffieri , Mildren A. Del-Sueldo , Gonzalo Miranda , Nicolás F. Renna , Rosana M. Quintana , Melisa N. Lassus , María-Rosa Galván , Romina Maldonado , Flavia A. Passarino , Lautaro N. Fierro , Lautaro L. Velez , Laura Graziani , Boris Kisluk , Leonel A. Berbotto , Romina Nieto , Rubén F. Mamprin D´andrea , Guillermo A. Berbotto , Jorge O. Galindez","doi":"10.1016/j.ajpc.2025.100942","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>Traditional cardiovascular risk (CVR) stratification does not consider CVR enhancers (CVRE). Women present under-recognized CVRE factors that may lead to arterial stiffness (AS). AS is associated with long-term cardiovascular disease. AS can be determined by carotid-femoral pulse wave velocity (cf-PWV). In women with low-CVR and a CVRE, our objective was to determine cf-PWV values and AS, and to compare with a control group.</div></div><div><h3>Material and Methods</h3><div>Multicentric cross-sectional study, from 2022 to 2024 in Argentina. Included women between 18 and 59 years-old, without traditional CVR-factors, low (<5 %) 10-year CVR, and office blood-pressure (BP) <140/90 mmHg. Inclusion criteria: Group 1: presence of a CVRE (history of gestational hypertension, preeclampsia; autoimmune rheumatic or hematological disease in clinical remission; previous oncological treatment in current complete remission; history of abortions; early menopause or menarche; anxiety or depression disorder; human immunodeficiency virus infected virally suppressed). Group-2: women who attended routine control. Exclusion criteria: hypertension; diabetes; target organ damage; chronic kidney disease; current smoking; history of CV-event; statins, aspirin, or antihypertensive treatment.</div></div><div><h3>Results</h3><div>Included 280 women: Group-1 (N = 174); Group-2 (N = 106). Group-1 showed higher cf-PWV: 7.02±1.20 vs. 5.71±0.86 (<em>p</em> < 0.0001) and higher AS frequency: 52.9 % vs. 0.9 % (<em>p</em> < 0.0001). A sub-analysis performed in the 199 women with office-BP <130/85 mmHg and central (aortic) systolic-BP was <121 mmHg also showed higher cf-PWV 6.70±1.07 vs. 5.62±0.78 (<em>p</em> < 0.0001) and higher AS: 43.4 % vs. 0.0 % (<em>p</em> < 0.0001) in Group-1. cf-PWV values maintain related with CVRE presence (<em>p</em> < 0.0001) at multivariate analysis.</div></div><div><h3>Conclusions</h3><div>Women with CVRE showed greater cf-PWV and higher frequency of AS.</div></div>","PeriodicalId":72173,"journal":{"name":"American journal of preventive cardiology","volume":"21 ","pages":"Article 100942"},"PeriodicalIF":4.3000,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of preventive cardiology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666667725000157","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives

Traditional cardiovascular risk (CVR) stratification does not consider CVR enhancers (CVRE). Women present under-recognized CVRE factors that may lead to arterial stiffness (AS). AS is associated with long-term cardiovascular disease. AS can be determined by carotid-femoral pulse wave velocity (cf-PWV). In women with low-CVR and a CVRE, our objective was to determine cf-PWV values and AS, and to compare with a control group.

Material and Methods

Multicentric cross-sectional study, from 2022 to 2024 in Argentina. Included women between 18 and 59 years-old, without traditional CVR-factors, low (<5 %) 10-year CVR, and office blood-pressure (BP) <140/90 mmHg. Inclusion criteria: Group 1: presence of a CVRE (history of gestational hypertension, preeclampsia; autoimmune rheumatic or hematological disease in clinical remission; previous oncological treatment in current complete remission; history of abortions; early menopause or menarche; anxiety or depression disorder; human immunodeficiency virus infected virally suppressed). Group-2: women who attended routine control. Exclusion criteria: hypertension; diabetes; target organ damage; chronic kidney disease; current smoking; history of CV-event; statins, aspirin, or antihypertensive treatment.

Results

Included 280 women: Group-1 (N = 174); Group-2 (N = 106). Group-1 showed higher cf-PWV: 7.02±1.20 vs. 5.71±0.86 (p < 0.0001) and higher AS frequency: 52.9 % vs. 0.9 % (p < 0.0001). A sub-analysis performed in the 199 women with office-BP <130/85 mmHg and central (aortic) systolic-BP was <121 mmHg also showed higher cf-PWV 6.70±1.07 vs. 5.62±0.78 (p < 0.0001) and higher AS: 43.4 % vs. 0.0 % (p < 0.0001) in Group-1. cf-PWV values maintain related with CVRE presence (p < 0.0001) at multivariate analysis.